EPCAM and colorectal cancer: CAR‐T cells targeting EpCAM on human ovarian and colorectal cancer cells are capable of killing the cancer cells in vitro, and the adoptive transfer of these CAR‐T cells resulted in prolonged animal survival by eradicating the established ovarian xenografts52